title: Transplantation-related toxicity and acute intestinal graft-versus-host disease after conditioning regimens intensified with Rhenium 188-labeled anti-CD66 monoclonal antibodies.
authors.forename: Stefan A
authors.initials: SA
authors.lastname: Klein
authors.forename: Stella
authors.initials: S
authors.lastname: Hermann
authors.forename: Johann Wolfgang
authors.initials: JW
authors.lastname: Dietrich
authors.forename: Dieter
authors.initials: D
authors.lastname: Hoelzer
authors.forename: Hans
authors.initials: H
authors.lastname: Martin
mesh_terms: D000208:Acute Disease; D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D015703:Antigens, CD / Q000276:immunology; D000943:Antigens, Differentiation / Q000276:immunology; D015815:Cell Adhesion Molecules; D005260:Female; D006086:Graft vs Host Disease / Q000209:etiology*; D006801:Humans; D007938:Leukemia / Q000150:complications / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D016499:Radioimmunotherapy / Q000009:adverse effects* / Q000379:methods; D012211:Rhenium / Q000008:administration & dosage / Q000633:toxicity*; D019172:Transplantation Conditioning / Q000009:adverse effects* / Q000379:methods; D014184:Transplantation, Homologous / Q000009:adverse effects / Q000379:methods; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D000943:Antigens, Differentiation; C069847:CD66 antigens; D015815:Cell Adhesion Molecules; D012211:Rhenium